PPT-2 Vol 2, ESRD, Ch 2 Data Source: Special analyses, Medicare 5 percent sample. Medicare
Author : teresa | Published Date : 2024-03-13
Af Am African American AKI acute kidney injury CKD chronic kidney disease vol 2 Table 21 HP2020 CKD3 Increase the proportion of hospital patients who incurred acute
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "2 Vol 2, ESRD, Ch 2 Data Source: Spec..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
2 Vol 2, ESRD, Ch 2 Data Source: Special analyses, Medicare 5 percent sample. Medicare: Transcript
Af Am African American AKI acute kidney injury CKD chronic kidney disease vol 2 Table 21 HP2020 CKD3 Increase the proportion of hospital patients who incurred acute kidney injury who have followup renal evaluation in 6 months postdischarge Target 123. vol. 2 Figure 5.1 Adjusted all-cause mortality rates, overall and by modality. Vol. 2, ESRD, . Ch. 5. 3. Data Source: Reference Tables H.4, H.8, H.9, and H.10, and special analyses, USRDS ESRD Database. Adjusted for age, sex, race, and primary diagnosis. Ref: 2011 patients. Abbreviation: ESRD, end-stage renal disease.. valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . dialysis; . Tx. , transplant. . v. ol. . 2 Figure . 7.1. Incident & December 31 point prevalent ESRD patients (. aged 0-19 years). (a) Incidence . of ESRD in . children. Vol. 2, ESRD, . Ch. 7. 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 9.1 Trends in ESRD expenditures, 2004-2015. Data Source: USRDS ESRD Database; Reference Table K.1. Abbreviation: ESRD, end-stage renal disease. . valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . Vol. 1, CKD, . Ch. . 6. 2. Data source: Medicare 5 percent sample. Abbreviations: CKD, chronic kidney disease; CHF, congestive heart failure, DM, diabetes mellitus.. v. ol 1 Table . 6.1 Point prevalent distribution of Medicare fee-for-service patients aged 65+ and total annual costs of Medicare Parts A and B services, by DM, CHF, and/or CKD, 2012. Figure . 4.1 . Vascular access use at hemodialysis initiation, . from . the ESRD Medical Evidence form (CMS 2728), 2005-2013. Vol 2, ESRD, . Ch. 4. 2. 3. AV. fistula. AV graft. Catheter with maturing fistula. (bars; scale on right), and annual change (%) in the adjusted* incidence rate of ESRD . (lines; scale on left) in the U.S. population, 1996-2013. Vol 2, ESRD, Intro. 2. Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race.. CROWNWeb. for December 2014, restricted to patients as follows: Panel a: Dialysis patients initiating treatment for ESRD at least 1 year prior to December 1, 2014, and who were alive through December 31, 2014. Vol. 1, CKD, . Ch. 2. 2. Table A. ICD-9-CM Codes. 585.1. Chronic kidney disease, Stage 1. 585.2. Chronic kidney disease, Stage 2 (mild). 585.3. Chronic kidney disease, Stage 3 (moderate). 585.4. Chronic kidney disease, Stage 4 (severe). Adj. : age/sex/race/prior year hospitalization/comorbidities. Ref: 2012 patients. Abbreviations: CKD, chronic kidney disease.. vol 1 Figure 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years at risk) for Medicare patients aged 66 and older, by CKD status and year, . Adj. : age/sex/race. Ref: all patients, 2013. Abbreviation: CKD, chronic kidney disease.. Table 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years . at . risk) for Medicare patients aged 66 and older, by CKD status, 2013. Figure . 7.1 . Sources of prescription drug coverage in Medicare enrollees, by population, 2014. 2016 Annual Data Report, Vol 1, CKD, Ch . 7. 2. a The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php. . valvular. heart disease; VTE/PE, venous thromboembolism and pulmonary embolism.. Figure . 4.1 Prevalence . of cardiovascular diseases in patients with or without CKD, 2014 . . 2016 Annual Data Report, Vol 1, CKD, .
Download Document
Here is the link to download the presentation.
"2 Vol 2, ESRD, Ch 2 Data Source: Special analyses, Medicare 5 percent sample. Medicare"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
